Science. 1991 Dec 6;254(5037):1515-8.

NMDA antagonist neurotoxicity: mechanism and prevention.

Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA.

Source

Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110.

Abstract

Antagonists of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor, including phencyclidine (PCP) and ketamine, protect against brain damage in neurological disorders such as stroke. However, these agents have psychotomimetic properties in humans and morphologically damage neurons in the cerebral cortex of rats. It is now shown that the morphological damage can be prevented by certain anticholinergic drugs or by diazepam and barbiturates, which act at the gamma-aminobutyric acid (GABA) receptor-channel complex and are known to suppress the psychotomimetic symptoms caused by ketamine. Thus, it may be possible to prevent the unwanted side effects of NMDA antagonists, thereby enhancing their utility as neuroprotective drugs.

PMID:: 1835799; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity. [Mol Psychiatry. 2002]
Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity.
Farber NB, Kim SH, Dikranian K, Jiang XP, Heinkel C. Mol Psychiatry. 2002; 7(1):32-43.
Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors. [Brain Res. 1996]
Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
Widdowson PS, Gyte AJ, Upton R, Wyatt I. Brain Res. 1996 Nov 4; 738(2):236-42.
Review [NMDA receptor antagonist neurotoxicity and psychotomimetic activity]. [Masui. 2003]
Review [NMDA receptor antagonist neurotoxicity and psychotomimetic activity].
Nakao S, Nagata A, Masuzawa M, Miyamoto E, Yamada M, Nishizawa N, Shingu K. Masui. 2003 Jun; 52(6):594-602.
Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK-801) injures pyramidal neurons in rat retrosplenial cortex. [Eur J Neurosci. 2000]
Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK-801) injures pyramidal neurons in rat retrosplenial cortex.
Tomitaka S, Tomitaka M, Tolliver BK, Sharp FR. Eur J Neurosci. 2000 Apr; 12(4):1420-30.
Review The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. [Brain Res Brain Res Rev. 1995]
Review The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias.
Ellison G. Brain Res Brain Res Rev. 1995 Feb; 20(2):250-67.

See reviews... See all...

Cited by 19 PubMed Central articles

Baseline gamma power during auditory steady-state stimulation in schizophrenia. [Front Hum Neurosci. 2011]
Baseline gamma power during auditory steady-state stimulation in schizophrenia.
Spencer KM. Front Hum Neurosci. 2011; 5:190. Epub 2012 Jan 13.
NMDA receptor function, memory, and brain aging. [Dialogues Clin Neurosci. 2000]
NMDA receptor function, memory, and brain aging.
Newcomer JW, Farber NB, Olney JW. Dialogues Clin Neurosci. 2000 Sep; 2(3):219-32.
Review The thalamic reticular nucleus and schizophrenia. [Schizophr Bull. 2011]
Review The thalamic reticular nucleus and schizophrenia.
Ferrarelli F, Tononi G. Schizophr Bull. 2011 Mar; 37(2):306-15. Epub 2010 Dec 3.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

NMDA antagonist neurotoxicity: mechanism and prevention.
NMDA antagonist neurotoxicity: mechanism and prevention.
Science. 1991 Dec 6 ;254(5037):1515-8.

PubMed
A virtual screen for diverse ligands: discovery of selective G protein-coupled r...
A virtual screen for diverse ligands: discovery of selective G protein-coupled receptor antagonists.
J Am Chem Soc. 2008 Apr 16 ;130(15):5115-23. Epub 2008 Mar 22 .

PubMed
Testicular microlithiasis in Taiwanese men.
Testicular microlithiasis in Taiwanese men.
Arch Androl. 2007 Nov-Dec ;53(6):339-44.

PubMed
[Motivational interviewing for cannabis users with psychotic disorders].
[Motivational interviewing for cannabis users with psychotic disorders].
Encephale. 2007 Oct ;33(5):819-26.

PubMed
Phytate: impact on environment and human nutrition. A challenge for molecular br...
Phytate: impact on environment and human nutrition. A challenge for molecular breeding.
J Zhejiang Univ Sci B. 2008 Mar ;9(3):165-91.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

NMDA antagonist neurotoxicity: mechanism and prevention.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 19 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information